Department of Physical Sciences, Rhode Island College, 600 Mount Pleasant Avenue, Providence, Rhode Island 02908, United States.
Biochemistry. 2024 May 7;63(9):1107-1117. doi: 10.1021/acs.biochem.3c00670. Epub 2024 Apr 26.
DNA polymerase θ (Pol θ or POLQ) is primarily involved in repairing double-stranded breaks in DNA through an alternative pathway known as microhomology-mediated end joining (MMEJ) or theta-mediated end joining (TMEJ). Unlike other DNA repair polymerases, Pol θ is thought to be highly error-prone yet critical for cell survival. We have identified several POLQ gene variants from human melanoma tumors that experience altered DNA polymerase activity, including a propensity for incorrect nucleotide selection and reduced polymerization rates compared to WT Pol θ. Variants are 30-fold less efficient at incorporating a nucleotide during repair and up to 70-fold less accurate at selecting the correct nucleotide opposite a templating base. This suggests that aberrant Pol θ has reduced DNA repair capabilities and may also contribute to increased mutagenesis. Moreover, the variants were identified in established tumors, suggesting that cancer cells may use mutated polymerases to promote metastasis and drug resistance.
DNA 聚合酶θ(Polθ 或 POLQ)主要通过一种称为微同源介导末端连接(MMEJ)或θ介导末端连接(TMEJ)的替代途径参与修复双链 DNA 断裂。与其他 DNA 修复聚合酶不同,Polθ 被认为高度易错,但对细胞存活至关重要。我们已经从经历 DNA 聚合酶活性改变的人类黑色素瘤肿瘤中鉴定出几种 POLQ 基因变异体,包括与 WT Polθ 相比,不正确核苷酸选择的倾向和聚合速率降低。在修复过程中,变体核苷酸的掺入效率降低了 30 倍,而相对于模板碱基,正确核苷酸的选择准确性降低了 70 倍。这表明异常 Polθ 的 DNA 修复能力降低,并且还可能导致增加的突变。此外,这些变体在已建立的肿瘤中被鉴定出来,表明癌细胞可能利用突变的聚合酶来促进转移和耐药性。